Zobrazeno 1 - 10
of 86
pro vyhledávání: '"G. Boeri"'
Autor:
Guido Luzzatto, Jacqueline Conard, Sandra Toffoli, Giuseppe Cella, Saida Manai, Antonio Girolami, Rossella Paolini, G. Boeri, Meyer Michel Samama, William Strauss, Alessandro Vianello
Publikováno v:
Hematology. 2:235-241
Platelet factor 4 (PF4) and tissue factor pathway inhibitor (TFPI) are two proteins with high affinity for heparin. They are each stored in platelets, as well as on endothelial cell surfaces, from where both are displaced or released following an inj
Autor:
Francesco Fiorin, Marino Gorinati, Rossella Paolini, G. Boeri, Maria Teresa Sartori, Antonio Girolami
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 2:60-63
We describe a new case of congenital hypofi brinogenemia revealed by the dramatic occurrence of a perinatal intracranial hemorrhage, which resulted in dif fuse multicystic encephalopathy with severe hydroceph alus. The family history was negative for
Autor:
Stefano Piermarocchi, G. Boeri, Antonio Girolami, Giovanni M. Patrassi, M.L. Viero, M. T. Sartori
Publikováno v:
Journal of Internal Medicine. 234:619-623
A new kindred with heterozygous plasminogen deficiency type I is described. The proband, a 17-year-old male, showed a peculiar thrombotic-like retinal picture compatible with Coats' disease. Extensive coagulation studies revealed decreased levels of
Publikováno v:
Fibrinolysis. 6:99-103
A family with defective fibrinolytic abnormalities and recurrent thrombotic events is described. Impaired fibrinolysis was associated with high activity and concentration of fast-acting plasminogen activators inhibitor (PAI-1). Acquired conditions as
Autor:
Vittorio Ilario Terribile, Guido Luzzatto, Graziella Saggiorato, G. Boeri, Rossella Paolini, Giuseppe Cella
Publikováno v:
Angiology. 43:59-62
There is a controversy about whether or not histidine-rich glycoprotein (HRG), the most abundant plasma protein with glycosaminoglycans-neutralizing capacity, is able to prevent the inhibition of human thrombin by heparin cofactor II (HC II) in the p
Publikováno v:
Scopus-Elsevier
Thrombotic events are often due to fibrinolytic defects such as impaired tissue plasminogen activator (tPA) synthesis and/or release or increased plasminogen activator inhibitor (PAI) levels. In this report we describe four members of a family with a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
SACRIPANTI A, M. E. BELLI, G. BOERI, S. FABBRI, L. MIRABILE, E. SASSI, L. ROSSI, ZURLINI, Giovanni
ottobre 1990: 83-87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4034::5e81f18ae951a15e513046f67156b2ec
https://hdl.handle.net/11587/103364
https://hdl.handle.net/11587/103364
Autor:
Ernesto Rampin, Alessandra Sbarai, Ugo Vertolli, Giuseppe Cella, William Strauss, G. Boeri, Agostino Naso, Alessandro Vianello
Publikováno v:
Thrombosis research. 81(6)
We studied tissue factor pathway inhibitor (TFPI) activity during hemodialysis in 10 uremic patients who were not receiving anticoagulant for at least 120 minutes. TFPI activity before dialysis was normal (patients 107 +/- 5.8%, controls 104 +/- 4.5%
Autor:
Elena Pontara, Alessandra Casonato, D. Dannhauser, Antonella Bertomoro, M. T. Sartori, G. Boeri, Antonio Girolami, G.M. Patrassi
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 6(6)
The acute simultaneous release of tissue plasminogen activator (t-PA) and von Willebrand factor (vWF) from endothelial cells in response to a variety of agonists including thrombin, DDAVP, histamine and adrenalin has been described. In the present st